Cooper CJ, Denyer SP, Maillard JY, Rapid and quantitative automated measurement of bacteriophage activity against cystic fibrosis isolates of Pseudomonas aeruginosa. J Appl Microbiol. 2011 Mar;110(3):631-40. doi: 10.1111/j.1365-2672.2010.04928.x. Epub 2011 Jan 12.
Cheeseman KE, Denyer SP, Hosein IK, Williams GJ, Maillard JY, Evaluation of the bactericidal efficacy of three different alcohol hand rubs against 57 clinical isolates of S. aureus. J Hosp Infect. 2009 Aug;72(4):319-25. doi: 10.1016/j.jhin.2009.04.018. Epub 2009 Jul 10.
McGann P, Rozak DA, Nikolich MP, Bowden RA, Lindler LE, Wolcott MJ, Lathigra R, A novel brain heart infusion broth supports the study of common Francisella tularensis serotypes, J. Microbiol Methods. 2010 Feb: 80(2): 164-171. Epub 2009 Dec 11. PMID: 20005265 [PubMed - in process]
Prior S, Gander B, Lecároz C, et. al.,
Gentamicin-loaded microspheres for
reducing the intracellular Brucella abortus load
in infected monocytes, Journal
of Antimicrobial Chemotherapy (2004) 53, 981-988.
(CN00216)
Geisler N, Gattringer R, Graninger W,
Georgopoulos A, Linezolid in
combination with vancomycin and teicoplanin
against MRSA by spectrophotometric optical density
measurements, Austrian Health
Communication, Antibiotika Monitor - 3/4/2003,
10th Scientific Meeting of European Society of
Chemotherapy, Poster Session, Poster P 80.
(CN00278)
Geisler N, Gattringer R, Graninger W,
Georgopoulos A, [Wirksamkeit von
Teicoplanin oder Vancomycin in Kombination mit
Linezolid gegenüber Methicillin-resistentem
Staphylococcus aureus mittels
spektrophotometrischer Trübungsmessung]
(Ger.), Austrian Health
Communication, Antibiotika Monitor - 6/2003,
Teicoplanin als First-Line-Antibiotikum.
(CN00507)
Odenholt I, Gustafsson I, Löwdin E, Postantibiotic and Sub-MIC Effects of Benzylpenicillin against Streptococcus pneumoniae with Different Susceptibilities for Penicillin, Chemotherapy 2003;49:287-293. (CN00334)
Odenholt I, Löwdin E, Cars O,
Postantibiotic, Postantibiotic
Sub-MIC, and Subinhibitory Effects of PGE-9509924,
Ciprofloxacin, and Levofloxacin, Antimicrobial Agents and Chemotherapy, October
2003, p. 3352-3356, Vol. 47, No. 10.
(CN00336)
Qvarnström Y, Sulphonamide
Resistance in Neisseria meningitidis and Commensal
Neisseria Species, Acta Universitatis
Upsaliensis, Comprehensive
Summaries of Uppsala Dissertations from the
Faculty of Medicine, 1301, 47 pp, 2003, Uppsala,
ISBN 91-554-5783-5. (CN00396)
Rabsch W, Methner U, Voigt W, Tschape H,
Reissbrodt R, Williams PH, Role of
receptor proteins for enterobactin and
2,3-dihydroxybenzoylserine in virulence of
Salmonella enterica, Infect
Immun. 2003 Dec;71(12):6953-6961 .
(CN00371)
Walsh SE, Maillard JY, Russell AD, Catrenich CE,
Charbonneau DL, Bartolo RG,
Activity and mechanisms of action
of selected biocidal agents on Gram-positive and
-negative bacteria, Journal of
Applied Microbiology, 2003 Feb, vol. 94, No. 2,
pp. 240-247 . (CN00034)
Daelemans D, Afonina E, Nilsson J, Werner G,
Kjems J, De Clercq E, Pavlakis GN, Vandamme AM,
A synthetic HIV-1 Rev inhibitor
interfering with the CRM1-mediated nuclear export,
Reprint (PDF):, Proceedings of
the National Academy of Sciences, USA, Vol. 99,
Issue 22, 14440-14445, October 29, 2002, Published
online before print October 9, 2002,
10.1073/pnas.212285299. (CN00030)
Kuipers ME, Beljaars L, Van Beek N, et. al.,
Conditions influencing the in vitro
antifungal activity of lactoferrin combined with
antimycotics against clinical isolates of
Candida, Apmis, Volume 110,
Issue 4, Page 290-298, April 2002.
(CN00127)
Meylaers K, Cerstiaens A, Vierstraete E, Baggerman
G, Michiels CW, De Loof A, Schoofs L,
Antimicrobial Compounds of Low
Molecular Mass are Constitutively Present in
Insects: Characterisation of
ß-Alanyl-Tyrosine, Current
Pharmaceutical Design, 2002, 8, pp. 99-110.
(CN00060)
Meylaers K, Cerstiaens A, Vierstraete E, Baggerman
G, Michiels CW, De Loof A, Schoofs L,
Antimicrobial compounds of low
molecular mass are constitutively present in
insects: characterisation of
beta-alanyl-tyrosine, Current
Pharmaceutical Design, 2002, 8, pp. 99-110.
(CN00061)
Alander M, Mättö J, Kneifel W, et. al.,
Effect of galacto-oligosaccharide
supplementation on human faecal microflora and on
survival and persistence of Bifidobacterium lactis
Bb-12 in the gastrointestinal
tract,International Dairy
Journal, Volume 11, Issue 10 , 2001, Pages
817-825. (CN00162)
Aroutcheva A, Gariti D, Simon M, et. al., Defense factors of vaginal lactobacilli, American Journal of Obstetrics & Gynecology, 185(2):375-379, August 2001. (CN00138)
Charteris WP, Kelly PM, Morelli L, Collins JK,
Antibacterial activity associated
with Lactobacillus gasseri ATCC 9857 from the
human female genitourinary
tract, World Journal of
Microbiology and Biotechnology (2001), 17(6),
615-625. (CN00050)
Georgopoulos A, Graninger W, Bezecny P, Buxbaum
A, In vitro activity of fosfomycin
combined with glycopeptides, moxifloxacin,
gentamicin and ampicillin against Enterococci,
assessed by the modified spectrophotometric
method, Poster, Wien, Austria,
2001, Abstract: P540, 1 pp. Citation: Clinical
Microbiology and Infection, volume 7, supplement
1, 2001, (394 pp). (CN00252)
Lambert RJW, Joynson J, Forbes B,
The relationships and
susceptibilities of some industrial, laboratory
and clinical isolates of Pseudomonas aeruginosa to
some antibiotics and biocides, Journal of Applied Microbiology, Volume 91, Issue
6, Page 972-984, Dec 2001. (CN00429)
Matinaho S, von Bonsdorff L, Rouhiainen A, et. al., Dependence of Staphylococcus epidermidis on non-transferrin-bound iron for growth,FEMS Microbiology Letters 196 (2001) pp. 177-182. (CN00139)
Simoes JA, Aroutcheva AA, Shott S, Faro S, Effect of metronidazole on the growth of vaginal lactobacilli in vitro, Infectious Diseases in Obstetrics and Gynecology, 2001, 9: 41-45. (CN00164)
Chiron J, Lamande J, Moussa F, Trivin F, Ceolin R, [Effect of micronized C60 fullerene on the microbial growth in vitro] (French), Annales pharmaceutiques francaises, 2000, May, 58(3), 170-175. (CN00483)
Gelfand EB, . Tsedenzhapov ETs, Karabak VI, et. al., [Efficacy of Meropenem in the Management of Abdominal Sepsis in Surgical Patients] (Russ.), Antibiotiki i Chimoterapia (Russ.), 2000, 45; 5. (CN00484)
Georgopoulos A, Bezecny P, Buxbaum A, Graninger W,
[Aktivität von Fosfomycin in
Kombination mit Ampicillin, Gentamicin,
Moxifloxacin, Vancomycin und Teicoplanin gegenüber
Enterokokken mittels Bioscreen-C-Analyzer]
(Ger.), Austrian Health
Communication, Antibiotika Monitor - 5/6/2000.
(CN00472)
Parkkinen J, von Bonsdorff L, Peltonen S, et. al.,
Catalytically active iron and
bacterial growth in serum of haemodialysis
patients after i.v. iron–saccharate
administration, Nephrol Dial
Transplant (2000) 15: 1827-1834. (CN00106)
Blomqvist G, Wesslen L, Påhlson C, et. al.,
Phylogenetic Placement and
Characterization of a New Alpha-2 Proteobacterium
Isolated from a Patient with
Sepsis, Journal of Clinical
Microbiology, Aug. 1997, p. 1988-1995.
(CN00328)
Lundberg JON, Carlsson S, Engstrand L, et. al., Urinary nitrite: more than a marker of infection, Urology, Volume 50, Issue 2, August 1997, Pages 189-191. (CN00450)
Minelli EB, Benini A, Bassi C, et. al., Antimicrobial activity of human pancreatic juice and its interaction with antibiotics, Antimicrobial Agents and Chemotherapy, 1996, vol. 40, (9), pp. 2099-2105. (CN00055)
Van Eldere J, Joosten L, Verhaeghe A, Surmont I,
Fluconazole and Amphotericin B
antifungal susceptibility testing by National
Committee for Clinical Laboratory Standards broth
macrodilution method commpared with E-test and
semiautomated broth microdilution
test, Journal of Clinical
Microbiology, 1996, vol. 34, (4), pp. 842-847.
(CN00199)
Kingsley R, Rabsch W, Stephens P, et. al.,
Iron supplying systems of
Salmonella in diagnostics, epidemiology and
infection, FEMS Immunology and
Medical Microbiology, 1995, vol. 11, pp. 257-264.
(CN00272)
Odenholt-Tornqvist I, Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem, Journal of Antimicrobial Chemotherapy 31: (1993) 881-892. (CN00393)
Antonov VS, Kulikova TA, Shestakova LA, Shibanov
AN, [A method of determining the
degree of bacteriuria and its detection using the
Bioscreen system], (Russ.), Antibiotiki i Khimoterapija, 1991, vol. 36, (4),
pp. 28-30. (CN00471)
Antonov VS, Kulikova TA, Shestakova LA, Shibanov
AN, [Procedure for detection of
bacteriuria and estimation of its level with the
Bioscreen system](Russ.),
Antibiotiki i Himoterapija, 1991, vol. 36, (4),
pp. 28-30. (CN00496)
Hedin G, Hambraeus A, Screening tests for the detection of methicillin resistance in Staphylococcus epidermis, Chemotherapy, 1991, vol. 28, (5), pp. 681-694. (CN00375)
Scalarone GM, Mikami Y, Kurita N, Ichihara Y,
Yazawa K, Miyaji M, Turbidometric
characterization of the postantifungal effect:
comparative studies with amphotericin B,
5-fluorocytosine and miconazole on Candida
albicans, (Eng.),Mycoses, 1991,
vol. 34, pp. 297-302. (CN00448)
Inoue M, Okubo T, Hashimoto H, [In vitro antibacterial activity of new macrolide antibiotic, rokitamycin] 28th ICAAC (Los Angeles)(jap), Toyo Jozo Co., Ltd, (904), 1988, 4-6 November, pp. 21-29. (CN00488)
Viljanen M, Procedure for automatic measuring of the minimum inhibitory concentrations (MIC) of twenty antimicrobial agents by Bioscreen,University of Turku, 1986, pp. 6. (CN00341)
Okubo T, Suzuki T, Fujita K, Iyobe S, Inoue M, Postantibiotic effects (PAE's) of macrolide antibiotics evaluated using Bioscreen C method, Japanese J. of Antibiotics, vol. 48, (4), pp. 548-52. (CN00335)
Wejdemar K, Vitamins that stimulate
the growth of Butyrivibrio fibrisolvens strains
grown in rumen fluid, Swedish
University of Agricultural Sciences, Department of
Animal Nutrition and Management, Kungsängen
Research Station; report, 1 pp. (CN00466)
|